Cases

Adang v Fischoff, 286 F.3d 1346 (Fed. Cir. 2002)

In re Brana, 51 F.3d 1560 (Fed. Cir. 1995) Chiron v Genentech, 363 F.3d 1247, 1252 (Fed. Cir. 2004)

Enzo Biochem, Inc. v Calgene, Inc., 188 F.3d

1362, 1375 n. 10 (Fed. Cir. 1999) Enzo Biochem, Inc. v Gen-Probe, Inc., 323 F.3d

956 (Fed. Cir. 2002) In re Goodman, 11 F.3d 1046 (Fed. Cir. 1993) J.E.M. Ag Supply v Pioneer Hi-Bred, 122 S.Ct. 593 (2001)

Madey v Duke University, 307 F.3d 1351 (Fed. Cir. 2002)

Merck KgaA v Integra Lifesciences I, 545 U.S. - (2005)

Monsanto v Bayer Bioscience, 363 F.3d 1235

(Fed. Cir. 2004) Plant Genetic Systems v DeKalb Genetics, 315

F.3d 1335 (Fed. Cir. 2003) Roche Products v Bolar Pharmaceutical, 733 F.2d 858 (Fed. Cir.), cert. denied, 469 US 856 (1984) University of Rochester v G.D. Searle, 358 F.3d 916 (Fed. Cir. 2004), denying reh. en banc, 2004 WL 1489101 (Fed. Cir. 2004) In re Vaeck, 947 F.2d 488 (Fed. Cir. 1991) In re Wands, 858 F.2d 731 (Fed. Cir. 1988) In re Wright, 999 F.2d 1557 (Fed. Cir. 1993)

Was this article helpful?

0 0

Post a comment